VISIOMED GROUP EO 0,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of 7V91 for the last semiannual is 7.33 M EUR, and it's 14.83% higher compared to the previous semiannual. The net income of H2 23 is 1.58 M EUR.